Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT06625320 |
| Title | Phase 3 Study of RMC-6236 in Patients with Previously Treated Metastatic Previously Treated Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) (RASolute 302) |
| Acronym | RASolute 302 |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase III |
| Variant Requirements | Yes |
| Sponsors | Revolution Medicines, Inc. |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| UCLA | RECRUITING | Los Angeles | California | 90095 | United States | Details |
| Memorial Sloan Kettering Cancer Center | RECRUITING | New York | New York | 10022 | United States | Details |
| Huntsman Cancer Institute | RECRUITING | Salt Lake City | Utah | 84112 | United States | Details |
| Virginia Cancer Specialists | RECRUITING | Fairfax | Virginia | 22031 | United States | Details |
| Pan-American Center for Oncology Trials | RECRUITING | San Juan | 00907 | Puerto Rico | Details |